BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

779 related articles for article (PubMed ID: 14555516)

  • 1. Meningiomas: analysis of loss of heterozygosity on chromosome 10 in tumor progression and the delineation of four regions of chromosomal deletion in common with other cancers.
    Mihaila D; Gutiérrez JA; Rosenblum ML; Newsham IF; Bögler O; Rempel SA;
    Clin Cancer Res; 2003 Oct; 9(12):4435-42. PubMed ID: 14555516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meningiomas: loss of heterozygosity on chromosome 10 and marker-specific correlations with grade, recurrence, and survival.
    Mihaila D; Jankowski M; Gutiérrez JA; Rosenblum ML; Newsham IF; Bögler O; Rempel SA;
    Clin Cancer Res; 2003 Oct; 9(12):4443-51. PubMed ID: 14555517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequent loss of chromosome 14 in atypical and malignant meningioma: identification of a putative 'tumor progression' locus.
    Menon AG; Rutter JL; von Sattel JP; Synder H; Murdoch C; Blumenfeld A; Martuza RL; von Deimling A; Gusella JF; Houseal TW
    Oncogene; 1997 Feb; 14(5):611-6. PubMed ID: 9053860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a consistent region of allelic loss on 1p32 in meningiomas: correlation with increased morbidity.
    Sulman EP; Dumanski JP; White PS; Zhao H; Maris JM; Mathiesen T; Bruder C; Cnaan A; Brodeur GM
    Cancer Res; 1998 Aug; 58(15):3226-30. PubMed ID: 9699646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GADD45A and EPB41 as tumor suppressor genes in meningioma pathogenesis.
    Piaskowski S; Rieske P; Szybka M; Wozniak K; Bednarek A; Płuciennik E; Jaskolski D; Sikorska B; Liberski PP
    Cancer Genet Cytogenet; 2005 Oct; 162(1):63-7. PubMed ID: 16157202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of heterozygosity for loci on chromosome 10 is associated with morphologically malignant meningioma progression.
    Rempel SA; Schwechheimer K; Davis RL; Cavenee WK; Rosenblum ML
    Cancer Res; 1993 May; 53(10 Suppl):2386-92. PubMed ID: 8485725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inactivation patterns of NF2 and DAL-1/4.1B (EPB41L3) in sporadic meningioma.
    Nunes F; Shen Y; Niida Y; Beauchamp R; Stemmer-Rachamimov AO; Ramesh V; Gusella J; MacCollin M
    Cancer Genet Cytogenet; 2005 Oct; 162(2):135-9. PubMed ID: 16213361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive DNA copy number profiling of meningioma using a chromosome 1 tiling path microarray identifies novel candidate tumor suppressor loci.
    Buckley PG; Jarbo C; Menzel U; Mathiesen T; Scott C; Gregory SG; Langford CF; Dumanski JP
    Cancer Res; 2005 Apr; 65(7):2653-61. PubMed ID: 15805262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allelic losses on chromosomes 14, 10, and 1 in atypical and malignant meningiomas: a genetic model of meningioma progression.
    Simon M; von Deimling A; Larson JJ; Wellenreuther R; Kaskel P; Waha A; Warnick RE; Tew JM; Menon AG
    Cancer Res; 1995 Oct; 55(20):4696-701. PubMed ID: 7553651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequently deleted loci on chromosome 9 may harbor several tumor suppressor genes in human renal cell carcinoma.
    Grady B; Goharderakhshan R; Chang J; Ribeiro-Filho LA; Perinchery G; Franks J; Presti J; Carroll P; Dahiya R
    J Urol; 2001 Sep; 166(3):1088-92. PubMed ID: 11490304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NF2 gene mutations and allelic status of 1p, 14q and 22q in sporadic meningiomas.
    Leone PE; Bello MJ; de Campos JM; Vaquero J; Sarasa JL; Pestaña A; Rey JA
    Oncogene; 1999 Apr; 18(13):2231-9. PubMed ID: 10327069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Detailed mapping and clinical significance of loss of heterozygosity on 9p13-23 in laryngeal squamous cell carcinoma by microsatellite analysis].
    Xu XF; Tang PZ; Cheng SJ
    Ai Zheng; 2003 May; 22(5):452-7. PubMed ID: 12753701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BCR expression is decreased in meningiomas showing loss of heterozygosity of 22q within a new minimal deletion region.
    Wozniak K; Piaskowski S; Gresner SM; Golanska E; Bieniek E; Bigoszewska K; Sikorska B; Szybka M; Kulczycka-Wojdala D; Zakrzewska M; Zawlik I; Papierz W; Stawski R; Jaskolski DJ; Och W; Sieruta M; Liberski PP; Rieske P
    Cancer Genet Cytogenet; 2008 May; 183(1):14-20. PubMed ID: 18474292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1p and 3p deletions in meningiomas without detectable aberrations of chromosome 22 identified by comparative genomic hybridization.
    Carlson KM; Bruder C; Nordenskjöld M; Dumanski JP
    Genes Chromosomes Cancer; 1997 Dec; 20(4):419-24. PubMed ID: 9408760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of heterozygosity on chromosomes 10 and 17 in clinically localized prostate carcinoma.
    Ittmann MM
    Prostate; 1996 May; 28(5):275-81. PubMed ID: 8610052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequent loss of heterozygosity in human primary squamous cell and colon carcinomas at 7q31.1: evidence for a broad range tumor suppressor gene.
    Zenklusen JC; Thompson JC; Klein-Szanto AJ; Conti CJ
    Cancer Res; 1995 Mar; 55(6):1347-50. PubMed ID: 7882334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
    Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detailed genetic and physical mapping of tumor suppressor loci on chromosome 3p in ovarian cancer.
    Fullwood P; Marchini S; Rader JS; Martinez A; Macartney D; Broggini M; Morelli C; Barbanti-Brodano G; Maher ER; Latif F
    Cancer Res; 1999 Sep; 59(18):4662-7. PubMed ID: 10493522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An 800-kb region of deletion at 13q14 in human prostate and other carcinomas.
    Chen C; Frierson HF; Haggerty PF; Theodorescu D; Gregory CW; Dong JT
    Genomics; 2001 Oct; 77(3):135-44. PubMed ID: 11597138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Minimal commonly deleted regions on chromosome 7q31 in primary gastric carcinoma and its clinical significance].
    Li JT; Fu L; Xia JC; Feng BJ; Mai SJ; Yu XJ; Huang LX; Feng QS; Pan ZZ; Zhan YQ
    Ai Zheng; 2005 Nov; 24(11):1306-11. PubMed ID: 16552953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.